UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 6, 2010
MMRGLOBAL, INC.
(Exact Name of Registrant as Specified in Charter)
|
DELAWARE |
|
000-51134 |
|
33-0892797 |
|
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer |
|
|
|
|
|
|
|
4401 WILSHIRE BLVD., SUITE 200 |
||||
|
(Address of Principal Executive Offices) |
||||
(310) 476-7002
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective December 6, 2010, Rich Teich will no longer serve as the Company's Executive Vice President. Due to substantially increased workloads in support of MMRPro and MMR Patient View, Mr. Teich has requested the Company enter into a new agreement with him to provide services focused on supporting the Company's products sold to healthcare professionals.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MMRGLOBAL, INC. |
|
|
December 10, 2010 |
By: /s/ Robert H. Lorsch |